[Effect of neovir in the treatment of acute hepatitis C].

Abstract

Fifteen male patients with acute hepatitis C aged 16-44 years were treated with neovir, an interferon inducer, administered intramuscularly in a daily dose of 250 mg 2-3 times a week for 3 months. By the end of this therapy the RNA of hepatitis C virus could still be detected in 84.6% of the patients, the characteristics of ALT, AST and alkaline phosphatase exceeded the norm more than twofold. The results of neovir therapy are regarded as ineffective.

• Authors: S L Maksimov, N D Iushchuk, I M Roslyĭ, A V Kravchenko, T V Danilova
• Journal: Zhurnal mikrobiologii, epidemiologii i immunobiologii (Zh Mikrobiol Epidemiol Immunobiol) 2001 May-Jun Issue 3 Pg. 84-7 ISSN: 0372-9311 [Print] Russia (Federation)
• Vernacular Title: Opyt primeneniia neovira pri lechenii ostrogo gepatita C.
• PMID: 11550570 (Publication Type: Clinical Trial, English Abstract, Journal Article)

Chemical References

• Acridines
• Interferon Inducers
• RNA, Viral
• Camedon
• Transaminases

Topics

• Acridines (therapeutic use)
• Acute Disease
• Hepacivirus (genetics)
• Hepatitis C (drug therapy)
• Humans
• Interferon Inducers (therapeutic use)
• Male
• RNA, Viral (blood)
• Transaminases (blood)